According to new research from Wake Forest University School of Medicine and colleagues. Up until age 80, older adults not only gain fat as they age – but because of the obesity epidemic – they actually begin their older years fatter.
Read More »Diabetes In Control
Benefit Of Actos For Teens With Type 1 Diabetes Unclear
Adding the diabetes drug Actos to insulin does not improve blood sugar control and may cause weight gain in adolescents who have type 1 diabetes who show signs of insulin resistance.
Read More »Higher Magnesium Intake Lowers Risk for Metabolic Syndrome and Diabetes
Magnesium intake in young adults is inversely proportional to the risk for metabolic syndrome, and diabetes according to the results of a prospective study.
Read More »Flaxseed Oil Lowers Blood Pressure
Regularly eating a diet supplemented with flaxseed oil may lower blood pressure and reduce risk of cardiovascular disease, according to a new study.
Read More »MannKind Corporation Will Submit for FDA Approval for It’s SUPRA Inhaled Insulin
It has been described by Jay Skyler, a leading diabetologist, as the first in a new class of diabetic therapies, “Supra-Rapid Acting Insulin’s”, that can change the way diabetes is treated.
Read More »Breakthrough In Diabetes-Related Blindness Made
Researchers have identified a group of proteins that may play critical roles in causing blood vessel leakage in the eyes of people with two forms of diabetic retinopathy.
Read More »Long-term Effects of Rosiglitazone on Lipid Concentrations and Body Weight
HDL-C and body weight increased and remained elevated.
Read More »Diabetics Who Delay Dialysis Can Improve Outcome
The nutritional status of patients with diabetes and chronic kidney disease can be maintained or even improved before they begin hemodialysis. However, the nutritional status deteriorates in those who have to start dialysis right away.
Read More »Half Of Americans Metabolize Sugar And Fat Differently Which Increases Diabetes
The gene variant appears to contribute to type 2 diabetes risk.
Read More »Pfizer Wants It’s Own GLP-1 to Drive Profits
Pfizer has overcome potential competition by buying out BioRexis, a company developing GLP-1 compounds that could prove to be powerful new diabetes treatments.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.